Because Ki-67 expression is an important prognostic marker in several cancer types, we have interrogated the R2 genomic platform and correlated Ki-67 expression to IFIT1 and STAT2 (both belonging to the interferon pathway that are upregulated upon Ki-67 degradation), and we have also tested this correlation experimentally. This evidence concerns the gene STAT2 and cancer.